Provided by Tiger Trade Technology Pte. Ltd.

3SBIO

21.440
-0.660-2.99%
Volume:28.02M
Turnover:600.74M
Market Cap:54.41B
PE:25.22
High:22.240
Open:21.480
Low:20.840
Close:22.100
52wk High:36.800
52wk Low:9.523
Shares:2.54B
HK Float Shares:2.54B
Volume Ratio:1.13
T/O Rate:1.10%
Dividend:0.25
Dividend Rate:1.17%
EPS(LYR):0.850
ROE:13.95%
ROA:6.19%
PB:2.93
PE(LYR):25.22
PS:5.27

Loading ...

Alphamab Oncology Names Former 3SBio Executive as CFO

MT Newswires Live
·
Mar 18

CMB International Foresees Accelerated Fundamental Improvement in China's Healthcare Sector, Recommends Buying Innovent Bio, 3SBIO, and Others

Stock News
·
Mar 17

Biopharma Stocks Rally as Sector Gains Strategic "Emerging Pillar" Status

Stock News
·
Mar 06

3SBio Inc. (01530) Publishes February 2026 Monthly Securities Return

Bulletin Express
·
Mar 03

UBS Forecasts 10% Revenue Growth for Healthcare Sector This Year, Names 3SBIO as Top Pick

Stock News
·
Mar 02

A Look At 3SBio (SEHK:1530) Valuation After Recent Share Price Strength

Simply Wall St.
·
Feb 10

BOCOM International Forecasts Continued Stable Growth for Healthcare Sector This Year, Recommends Seeking Undervalued Stocks

Stock News
·
Feb 05

3SBio Inc. (01530) Reports January 2026 Monthly Return

Bulletin Express
·
Feb 04

An Insider At 3SBio Lowered Their Holding Recently

Simply Wall St.
·
Feb 02

China Universal Asset Management Reduces Stake in 3SBIO (01530) by 1.7845 Million Shares at HK$26.45 Per Share

Stock News
·
Jan 21

HFT Investment Management Increases Stake in 3SBIO (01530) by 1.49 Million Shares at HK$28.18 Per Share

Stock News
·
Jan 16

3SBio Inc. (HKG:1530) Shares Could Be 48% Below Their Intrinsic Value Estimate

Simply Wall St.
·
Jan 15

BREAKINGVIEWS-Biotech boom shows innovation is now made in China

Reuters
·
Jan 05

Could The Market Be Wrong About 3SBio Inc. (HKG:1530) Given Its Attractive Financial Prospects?

Simply Wall St.
·
Dec 31, 2025

GRAND PHARMA (00512): Self-Developed Global Innovative Radiopharmaceutical GPN01530 Approved for Clinical Trials in the U.S.

Stock News
·
Dec 17, 2025

Pfizer faces challenging years on fading COVID sales, margin pressure

Reuters
·
Dec 16, 2025

Why 3SBio (SEHK:1530) Is Down 10.1% After HK$3.12 Billion Follow-on Equity Offering And Portfolio Shift

Simply Wall St.
·
Dec 15, 2025

3SBio (SEHK:1530): Reassessing Valuation After Share Placement and Hair-Loss Business Spin-Off

Simply Wall St.
·
Dec 14, 2025

Hong Kong Stock Short Interest Data as of December 12

Stock News
·
Dec 12, 2025

3SBIO (01530) Issues 105 Million Shares Under Placement Agreement

Stock News
·
Dec 09, 2025